Correlation Between Gilead Sciences and Equillium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Equillium, you can compare the effects of market volatilities on Gilead Sciences and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Equillium.

Diversification Opportunities for Gilead Sciences and Equillium

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Gilead and Equillium is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Equillium go up and down completely randomly.

Pair Corralation between Gilead Sciences and Equillium

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.28 times more return on investment than Equillium. However, Gilead Sciences is 3.52 times less risky than Equillium. It trades about 0.25 of its potential returns per unit of risk. Equillium is currently generating about -0.02 per unit of risk. If you would invest  8,772  in Gilead Sciences on September 19, 2024 and sell it today you would earn a total of  508.00  from holding Gilead Sciences or generate 5.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Equillium

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent essential indicators, Gilead Sciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Gilead Sciences and Equillium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Equillium

The main advantage of trading using opposite Gilead Sciences and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.
The idea behind Gilead Sciences and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device